BioSpace News Archive

Genetown

Concerto Biosciences Raises $23 Million in Series A to Advance Product Development, Expand Pipeline

Concerto Biosciences announced today that it raised $23 million in a Series A funding round led by Safar Partners and joined by Horizons Ventures and M Ventures.

November 2, 2022
·
5 min read
Blaze Bioscience Announces Enrollment is Complete on its Pivotal Phase 2/3 Trial of tozuleristide and the CanvasTM Imaging System in Pediatric Central Nervous System Tumors

Blaze Bioscience, Inc. the Tumor Paint Company® (Blaze), a biotechnology company dedicated to improving the lives of patients through development and commercialization of products for fluorescence guided cancer surgery, announced today that its pivotal Phase 2/3 study

November 2, 2022
·
3 min read
Biotech Beach

Biomerica InFoods® IBS Data Presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting

Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) announced that data derived from a clinical study of InFoods® IBS was presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting.

November 2, 2022
·
6 min read
Deals

OrsoBio Acquires ACMSD Inhibitor Program to Address Mitochondrial Dysfunction from Mitobridge, an Astellas Company

OrsoBio, Inc. today announced its acquisition of an ACMSD inhibitor program from Mitobridge, an Astellas Company.

November 2, 2022
·
4 min read
Business

OrsoBio Acquires Phase 2-Ready, Selective ACC2 Inhibitor from Shionogi & Co., Ltd. for the Treatment of Type 2 Diabetes

OrsoBio, Inc. today announced it has acquired exclusive worldwide rights to an ACC2 inhibitor program from Shionogi & Co., Ltd.

November 2, 2022
·
4 min read
Business

Minerva Neurosciences to Report Third Quarter 2022 Financial Results and Business Updates on November 9, 2022

Minerva Neurosciences, Inc. today announced that it will release financial results and business updates for the third quarter of 2022 on Wednesday, November 9, 2022.

November 2, 2022
·
1 min read
Business

Processa Pharmaceuticals to Host Conference Call to Discuss Third Quarter 2022 Results and Provide Drug Development Update on November 8, 2022 at 4:30 p.m. EST

Processa Pharmaceuticals, Inc. announces today it will host a conference call and live webcast on November 8, 2022, at 4:30 p.m. EST to discuss its third quarter 2022 results and provide an update on its clinical pipeline.

November 2, 2022
·
2 min read
Biotech Bay

PACT Pharma to Present New Data Highlighting First-of-its-Kind Personalized Neoantigen TCR T Cell Therapy Platform at SITC 2022

PACT Pharma, Inc. today announced that new data highlighting its first-of-its-kind adoptive T cell therapy platform will be featured in multiple presentations at the upcoming 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2022).

November 2, 2022
·
3 min read
Business

STAAR Surgical Reports Third Quarter Net Sales of $76 Million Up 30% Y/Y

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, reported financial results for the third quarter ended September 30, 2022.

November 2, 2022
·
18 min read
Business

Accuray Reports Fiscal 2023 First Quarter Financial Results

Accuray Incorporated reported financial results for the first quarter of fiscal 2023 ended September 30, 2022.

November 2, 2022
·
14 min read